The board of directors of Extrawell Pharmaceutical Holdings Limited announced that Mr. Xue Jing Lun, an independent non-executive Director, and a member of each of the audit committee, remuneration committee and nomination committee of the Company, passed away on 4 December 2022 due to illness. Following the passing away of Mr. Xue, the Board comprises six Directors, including four executive Directors and two independent non-executive Directors. The Company currently does not meet (i) the minimum number of independent non-executive directors required under Rule 3.10(1) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited; and (ii) the minimum number of members in the audit committee required under Rule 3.21 of the Listing Rules.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.042 HKD | -4.55% |
|
+5.00% | +23.53% |
28/06 | Extrawell Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
25/06 | Extrawell Pharmaceutical Warns of Swing to Loss in Fiscal Year 2024 | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+23.53% | 1.35Cr | |
+55.55% | 82TCr | |
+39.95% | 63TCr | |
-6.83% | 35TCr | |
+17.15% | 32TCr | |
+7.09% | 29TCr | |
+13.87% | 24TCr | |
+1.27% | 22TCr | |
+13.29% | 22TCr | |
+7.87% | 17TCr |
- Stock Market
- Equities
- 858 Stock
- News Extrawell Pharmaceutical Holdings Limited
- Extrawell Pharmaceutical Holdings Limited Announces Demise of Mr. Xue Jing Lun, Independent Non-Executive Director, and A Member of Each of the Audit Committee, Remuneration Committee and Nomination Committee